Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HCB-101 by HanchorBio for Solid Tumor: Likelihood of Approval
HCB-101 is under clinical development by HanchorBio and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
Data Insights
HCB-101 by HanchorBio for Non-Hodgkin Lymphoma: Likelihood of Approval
HCB-101 is under clinical development by HanchorBio and currently in Phase I for Non-Hodgkin Lymphoma. According to GlobalData, Phase I...